MIG

(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol


Toggle HydrogenToggle Labels

Chemical Component Summary

Name(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
SynonymsMiglitol
Identifiers(1R,2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
FormulaC8 H17 N O5
Molecular Weight207.224
TypeNON-POLYMER
Isomeric SMILESC1[C@@H]([C@H]([C@@H]([C@H]([N@@]1CCO)CO)O)O)O
InChIInChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1
InChIKeyIBAQFPQHRJAVAV-ULAWRXDQSA-N

Chemical Details

Formal Charge0
Atom Count31
Chiral Atom Count4
Bond Count31
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB00491 
NameMiglitol
Groups approved
DescriptionMiglitol inhibits the breakdown complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body. Miglitol should be taken at the start of a meal for maximal effect and the effect will depend on the amount of poly and oligosaccharides in the diet. Miglitol inhibits alpha-glucosidase, making less sugars available for digestion and reducing postprandial hyperglycemia. Unlike other drugs of the same class, miglitol is not metabolized and the unmetabolized drug is excreted by the kidneys.
Synonyms
  • Miglitolum
  • Miglitol
Brand Names
  • Glyset
  • Miglitol
IndicationFor use as an adjunct to diet to improve glycemic control in patients with non-insulin-dependent diabetes mellitus (NIDDM) whose hyperglycemia cannot be managed with diet alone.
Categories
  • Alimentary Tract and Metabolism
  • Alkaloids
  • Blood Glucose Lowering Agents
  • Carbohydrates
  • Drugs Used in Diabetes
ATC-CodeA10BF02
CAS number72432-03-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Lysosomal alpha-glucosidaseMGVRHPPCSHRLLAVCALVSLATAALLGHILLHDFLLVPRELSGSSPVLE...unknownantagonist
Neutral alpha-glucosidase ABMAAVAAVAARRRRSWASLVLAFLGVCLGITLAVDRSNFKTCEESSFCKRQ...unknownantagonist
Neutral alpha-glucosidase CMEAAVKEEISLEDEAVDKNIFRDCNKIAFYRRQKQWLSKKSTYQALLDSV...unknownantagonist
Maltase-glucoamylase, intestinalMARKKLKKFTTLEIVLSVLLLVLFIISIVLIVLLAKESLKSTAPDPGTTG...unknownantagonist,inhibitor
Pancreatic alpha-amylaseMKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPK...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1561
PubChem 441314
ChEMBL CHEMBL1561
ChEBI CHEBI:6935